🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-05-06
Trial ID
NCT07571551
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
Lenvatinib is an oral multi-target receptor tyrosine kinase inhibitor (TKI)...
Status
Unknown
Location
Third Affiliated Hospital, Sun Yat-Sen University
Start Date
2024-01-01
Trial ID
NCT05803928
Treatments Being Tested
This phase II, multicenter, single-arm, open-label study evaluates first-li...
Status
Not Yet Recruiting
Location
West China Hospital, Chengdu, Sichuan 610000
Start Date
2026-08
Trial ID
NCT07715565
Treatments Being Tested
Combination treatment with antiangiogenic agents and anti-programmed cell d...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2020-12-23
Trial ID
NCT04639284
Treatments Being Tested
CMN-001 is an autologous, tumor antigen-loaded dendritic cell immunotherapy...
Status
Terminated
Location
Moffitt Cancer Center
Start Date
2020-07-22
Trial ID
NCT04203901
Treatments Being Tested
This is an open-label, multi-center, single-arm, phase II study to evaluate...
Status
Withdrawn
Location
Zhongshan Hospital, Fudan University
Start Date
2024-05-31
Trial ID
NCT06361758
Treatments Being Tested
Purpose: This phase II clinical trial evaluates whether a combination of li...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07685535
Treatments Being Tested
This is a parallel assigned, open-label, perspective trial studying the saf...
Status
Unknown
Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2022-05-20
Trial ID
NCT05339581
This is a phase I/II multicenter, open-label umbrella platform study that w...
Status
Completed
Location
Liga Norte Riograndense Contra o Câncer ( Site 2303)
Start Date
2022-07-27
Trial ID
NCT05342636
Treatments Being Tested